Galapagos: Strong cash position...CF pipeline to accelerate

BUY, Fair Value EUR57 (0%)
News published on August Monday 24, 2015
Share on

GLPG’s cash position is above EUR400m (exc. milestones) and should enable the company to accelerate the development of its CF pipeline which has been overshadowed by filgotinib in H1. We expect major newsflow catalysts to occur for both the CF project as well as the proprietary pipeline in the second half of the year. We are buyers. 

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities